文献速递关节外科创伤骨科

三组件全踝关节置换术中植入物翻修的适应证是什么

What Are the Indications for Implant Revision in Three-component Total Ankle Arthroplasty?
PubMed 文献 · Clin Orthop Relat Res · 2021-01-01

该回顾性研究纳入2003至2017年接受单设计三组件全踝关节置换的1006例患者(1074踝),评估植入物翻修的累积发生率、适应证及相关因素。平均随访8.8年时翻修累积发生率为9.8%,5年和10年分别为4.8%和12.1%;翻修最常见原因为不稳定(34%),其次为无菌性松动(28%)。术前严重后足畸形及外翻畸形与翻修风险升高相关。

要点

  • 平均随访8.8年时植入物翻修累积发生率为9.8%(95%CI 7.7%至11.8%)。
  • 翻修最常见原因为不稳定(34%),其次为无菌性松动(28%)。
  • 术前严重后足畸形较轻微畸形(HR 1.9)或中立位(HR 2.5)翻修风险更高。

核心结论

  • 在该三组件设计全踝关节置换中,不稳定是比既往报道更常见的植入物翻修原因。
  • 全踝关节置换术中必须仔细处理所有导致后足内翻或外翻畸形的病因,以防止该植入物翻修。
  • 需要由未参与该植入物设计的医生或机构开展未来研究来证实这些发现,并进一步探究为何大量患者因不明原因疼痛而接受翻修。

研究设计与样本

  • 回顾性研究,2003年至2017年间由植入物设计者本人或其监督下完成单设计三组件全踝关节假体的初次全踝关节置换,共1006例患者(1074踝),年龄17至88岁,治疗终末期踝关节骨关节炎。
  • 68例双侧手术患者仅纳入首次全踝关节置换;2%(1006例中16例)失访,5%(1006例中55例)因与手术无关原因死亡,最终935例患者纳入评估。
  • 纳入患者的平均(范围)随访时间为8.8±4.2(0.2至16.8)年。
  • 翻修原因由两名足踝外科医生根据改良的既往方案分类为六类:无菌性松动、囊肿形成、不稳定、深部感染、技术错误及无其他原因的疼痛;分类基于共识 agreement。

主要发现

  • 平均(范围)随访时间8.8±4.2年(0.2至16.8)时,植入物翻修累积发生率为9.8%(95%CI 7.7%至11.8%)。
  • 全踝关节置换术后5年和10年累积发生率分别为4.8%(95%CI 3.4至6.1)和12.1%(95%CI 9.7%至14.5%)。
  • 翻修最常见原因为不稳定(34%[121例中41例]),其次为一个或多个金属组件无菌性松动(28%[121例中34例])、无其他原因疼痛(12%[121例中14例])、囊肿形成(10%[121例中12例])、深部感染(9%[121例中11例])和技术错误(7%[121例中9例])。
  • 术前严重后足畸形的踝较轻微畸形(HR 1.9[95%CI 1.2至3.0];p=0.007)或中立位(HR 2.5[95%CI 1.5至4.4];p=0.001)更可能接受翻修。
  • 术前后足外翻畸形较内翻畸形增加翻修概率(HR 2.1[95%CI 1.4至3.4];p=0.001)。

临床怎么用

  • 作者认为,全踝关节置换术中必须仔细处理所有导致后足内翻或外翻畸形的病因,以防止该植入物翻修。
  • 作者指出,需要由未参与该植入物设计的医生或机构开展未来研究来证实这些发现。

局限性

  • 需要由未参与该植入物设计的医生或机构开展未来研究来证实这些发现,并进一步探究为何大量患者因不明原因疼痛而接受翻修。
  • 2%(1006例中16例)失访,5%(1006例中55例)因与手术无关原因死亡。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Given the increasing usage of total ankle arthroplasty (TAA), a better understanding of the reasons leading to implant revision and the factors that might influence those indications is necessary to identify at-risk patients. QUESTION/PURPOSES: Using a single-design three-component ankle prosthesis, we asked: (1) What is the cumulative incidence of implant revision at 5 and 10 years? (2) What are the indications for implant revision in our population? (3) What factors are associated with an increased likelihood of implant revision during the time frame in question? METHODS: Between 2003 and 2017, primary TAA using a single-design three-component ankle implant was performed by or under the supervision of the implant designer in 1006 patients (1074 ankles) aged between 17 and 88 years to treat end-stage ankle osteoarthritis. No other TAA systems were used during the study period at the investigators' institution. In 68 patients with bilateral surgery, only the first TAA was considered. Of the patients treated with the study implant, 2% (16 of 1006) were lost to follow-up 5 to 14 years after TAA and were not known to have died or undergone revision, and 5% (55 of 1006) were deceased due to reasons unrelated to the procedure, leaving 935 patients for evaluation in this retrospective study. The mean (range) follow-up for the included patients was 8.8 ± 4.2 (0.2 to 16.8) years. Implant revision was performed 0.5 to 13.2 years after TAA in 12% (121 of 1006) of our patients. Survivorship free from revision was calculated using cumulative incidence (competing risks) survivorship, with death as a competing risk. The reason for each revision was classified into one of six categories according to a modified version of a previously published protocol: aseptic loosening, cyst formation, instability, deep infection, technical error, and pain without another cause. Two foot and ankle surgeons reviewed the records of all patients who underwent implant revision and assigned each patient's reason for revision to one of the six categories. The decision for assigning each patient to one of the six categories was made based on a consensus agreement. A subgroup classification of preoperative ankle alignment (neutral, mild, and major deformity) and variables of age, sex, BMI, etiology of ankle osteoarthritis, and number of preoperative and intraoperative hindfoot or midfoot procedures were used in a multinomial logistic regression and Cox regression analysis to estimate their association with reason for revision and implant survival until revision. RESULTS: The cumulative incidence of implant revision at the mean (range) follow-up time of 8.8 ± 4.2 years (0.2 to 16.8) was 9.8% (95% confidence interval 7.7% to 11.8%). Five and 10 years after TAA, cumulative incidence was 4.8% (95% CI 3.4 to 6.1) and 12.1% (95% CI 9.7% to 14.5%), respectively. The most common reason for revision was instability (34% [41 of 121]), followed by aseptic loosening of one or more metallic components (28% [34 of 121]), pain without another cause (12% [14 of 121]), cyst formation (10% [12 of 121]), deep infection (9% [11 of 121]), and technical error (7% [9 of 121]). Ankles with a major hindfoot deformity before TAA were more likely to undergo revision than ankles with a minor deformity (hazard ratio 1.9 [95% CI 1.2 to 3.0]; p = 0.007) or neutral alignment (HR 2.5 [95% CI 1.5 to 4.4]; p = 0.001). A preoperative hindfoot valgus deformity increased revision probability compared with a varus deformity (HR 2.1 [95% CI 1.4 to 3.4]; p = 0.001). CONCLUSION: Instability was a more common reason for implant revision after TAA with this three-component design than previously reported. All causes inducing either a varus or valgus hindfoot deformity must be meticulously addressed during TAA to prevent revision of this implant. Future studies from surgeons/institutions not involved in this implant design are needed to confirm these findings and to further investigate why a substantial number of patients had pain of unknown cause prompting revision. LEVEL OF EVIDENCE: Level III, therapeutic study.

来源:Clin Orthop Relat Res,查看原文。版权归原作者所有。

引用

  1. Richter D, Krähenbühl N, Susdorf R, et al. What Are the Indications for Implant Revision in Three-component Total Ankle Arthroplasty? Clin Orthop Relat Res. 2021. PMID: 33105302. doi:10.1097/CORR.0000000000001517

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。